Form 8-K - Current report:
SEC Accession No. 0001193125-26-211918
Filing Date
2026-05-07
Accepted
2026-05-07 16:12:11
Documents
10
Period of Report
2026-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alec-20260507.htm   iXBRL 8-K 46148
2 EX-99.1 alec-ex99_1.htm EX-99.1 83121
  Complete submission text file 0001193125-26-211918.txt   243537

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20260507.xsd EX-101.SCH 24837
13 EXTRACTED XBRL INSTANCE DOCUMENT alec-20260507_htm.xml XML 4686
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 26953392
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)